What's Actually Worth Measuring? Dr. Steven Lu's Short List | Episode 6 Preview

Watch the full episode →    • Longevity BS, Breakthroughs and What Comes...   One in eight US adults say they're currently taking a GLP-1 drug, and Australia's TGA has warned about a rise in unapproved peptide products. So what's actually worth measuring, taking or trusting? In this episode of What the Health, Emily Casey is joined by Dr Steven Lu, Co-founder and Chief Medical Officer at Everlab. Watch the full conversation for their analysis of lipoprotein(a) testing and the case for Medicare funding, body composition checks alongside GLP-1s, the risks of GLP-1s without clinical support, peptides and his "would I take it myself?" test, clinician-in-the-loop AI health chat, and the new pTau217 Alzheimer's blood test. Subscribe for more conversations cutting through the noise in health technology, biotech and healthcare innovation. What the Health: https://whatthehealth.io/ Everlab: https://www.everlab.com.au/ Tenmile Ventures: https://www.tenmile.com/ What the Health is brought to you in partnership with Tenmile Ventures. What the Health is part of Day One Network: https://dayone.fm/